• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER Back to Search Results
Model Number 1012451-12
Medical Device Problem Codes Material Rupture (1546); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/30/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was to treat a lesion in the left anterior descending (lad) artery with moderate calcification and moderate tortuosity.The 3.5x12mm nc trek balloon dilatation catheter (bdc) was soaked and prepared (air aspiration) outside the anatomy prior to use without issues.The balloon was advanced without resistance and inflated twice above the rated burst pressure (rbp).The balloon ruptured.There was no adverse patient effect and there was no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
H6: medical device problem code 2017 - above rbp.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
Visual and functional inspections were performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.It was reported by the account that the balloon was overinflated.It should be noted that the coronary dilatation catheters (cdc), nc trek, rx, global, instruction for use (ifu), warning section, states: balloon pressure should not exceed the rated burst pressure (rbp).The rbp for the nc trek device is 18 atm.In this case, it was reported that the balloon was inflated above rbp; however, a specific atmosphere was not provided.The investigation determined the reported balloon rupture appears to be related to operational context.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK CORONARY DILATATION CATHETER
Common Device Name
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16792923
Report Number2024168-2023-04210
Device Sequence Number6870058
Product Code LOX
UDI-Device Identifier08717648151972
UDI-Public08717648151972
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K103153
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2025
Device Model Number1012451-12
Device Catalogue Number1012451-12
Device Lot Number20226G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/31/2023
Supplement Date Received by Manufacturer05/10/2023
Initial Report FDA Received Date04/23/2023
Supplement Report FDA Received Date06/01/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/26/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-